Immune checkpoint inhibitor dosing: Can we go lower without compromising clinical efficacy?

Alex Renner, Mauricio Burotto, Carlos Rojas

Research output: Contribution to journalArticlepeer-review

52 Scopus citations

Fingerprint

Dive into the research topics of 'Immune checkpoint inhibitor dosing: Can we go lower without compromising clinical efficacy?'. Together they form a unique fingerprint.

Medicine & Life Sciences